Fundamental Valuation Report MediWound(MDWD:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$3.90 (USD) 05/06/2021 Weighted Valuation$3.95 (USD) Overall RatingFairly valued to slightly Undervalued by 1.3% Valuation Models Comparables: $3.95 (USD) …
MediWound (MDWD:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Maple Leaf Foods(MFI:TSE) Consumer Defensive:Packaged Foods This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$26.68 (CAD) 05/06/2021 Weighted Valuation$29.80 (CAD) Overall RatingUndervalued by 11.7% Valuation Models Adjusted …
Maple Leaf Foods (MFI:TSE) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Magnite(MGNI:NAS) Communication Services:Advertising Agencies This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.24 (USD) 05/06/2021 Weighted Valuation$16.00 (USD) Overall RatingOvervalued by 50.4% Valuation Models Comparables: $15.75 (USD) Valuation …
Magnite (MGNI:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Macrogenics(MGNX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$31.86 (USD) 05/06/2021 Weighted Valuation$31.57 (USD) Overall RatingFairly valued to slightly Overvalued by 0.9% Valuation Models Comparables: $24.70 (USD) …
Macrogenics (MGNX:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Mandalay Resources(MND:TSE) Basic Materials:Gold This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.30 (USD) / $2.79 (CAD) 05/07/2021 Weighted Valuation$3.61 (USD) / $4.37 (CAD) Use a …
Mandalay Resources (MND:TSE) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report MannKind(MNKD:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.29 (USD) 05/07/2021 Weighted Valuation$3.95 (USD) Overall RatingOvervalued by 7.9% Valuation Models Comparables: $2.59 (USD) Valuation Methods This …
MannKind (MNKD:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Brigham Minerals(MNRL:NYS) Energy:Oil & Gas E&P This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.44 (USD) 05/07/2021 Weighted Valuation$18.35 (USD) Overall RatingFairly valued to slightly Overvalued by 0.5% …
Brigham Minerals (MNRL:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Morguard(MRC:TSE) Real Estate:Real Estate – Diversified This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$128.16 (CAD) 05/07/2021 Weighted Valuation$169.45 (CAD) Overall RatingUndervalued by 32.2% Valuation Models Comparables: $240.30 …
Morguard (MRC:TSE) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Merck & Co(MRK:NYS) Healthcare:Drug Manufacturers – General This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$78.41 (USD) 05/07/2021 Weighted Valuation$79.39 (USD) Overall RatingFairly valued to slightly Undervalued by …
Merck & Co (MRK:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Mirati Therapeutics(MRTX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$144.00 (USD) 05/07/2021 Weighted Valuation$148.78 (USD) Overall RatingFairly valued to slightly Undervalued by 3.3% Valuation Models Comparables: $165.51 …
Mirati Therapeutics (MRTX:NAS) Fundamental Valuation Report Read more »
Read More